Korean J Urol Oncol.  2021 May;19(2):101-108. 10.22465/kjuo.2021.19.2.101.

Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer

Affiliations
  • 1Samsung Genome Institute, Samsung Medical Center, Seoul, Korea
  • 2Center for Health Promotion, Samsung Medical Center, Seoul, Korea

Abstract

Prostate cancer has long been considered a disease with a heterogeneous phenotype. The intratumor heterogeneity (ITH) may affect diverse phenotypes such as treatment response, drug resistance, and overall clinical outcomes. Despite technical advances over the past decade, we have an incomplete understanding of the extent and effects of ITH in prostate cancer progression. We present here a comprehensive review of the various studies dealing with ITH in prostate cancer. We discuss the advanced next-generation sequencing analyses including single cell sequencing and circulating cell-free DNA sequencing that have the impact of heterogeneity on clinical decision making.

Keyword

Prostate cancer, Intratumor heterogeneity, Next-generation sequencing, Clonality, Genomic marker
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr